Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06062342 · ClinicalTrials.gov registry record · NA

Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities

A NA study of HIV, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
20,400
Enrollment target
1
Study location

NCT06062342 is a NA study of HIV that is actively recruiting participants, run by University of Miami. The registered enrollment target is 20,400 participants, above the 373-participant average among 303 other HIV trials with a reported enrollment target (5369% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06062342, a NA study of HIV, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
20,400 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the effectiveness of the FPI bundled implementation strategy in increasing HIV testing, Pre-exposure prophylaxis (PrEP) linkage (e.g., prescription) and knowledge, and condom use/access.

Conditions Studied

Interventions

  • BEHAVIORAL FPI

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 20,400 participants
Start Date 2024-02-02
Est. Completion 2029-06-30
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT06062342

The ClinicalTrials.gov registry entry for NCT06062342 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20,400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 373-participant average among 303 other HIV trials with a reported enrollment target (5369% higher). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which FPI is the first listed.

NCT06062342 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06062342 about?

NCT06062342 is a clinical study titled "Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities". The purpose of this study is to assess the effectiveness of the FPI bundled implementation strategy in increasing HIV testing, Pre-exposure prophylaxis (PrEP) linkage (e.g., prescription) and knowledge, and condom use/access.

What is the current status of trial NCT06062342?

This trial is currently recruiting. It is a NA study. The enrollment target is 20,400 participants. The study started on 2024-02-02. Estimated completion is 2029-06-30.

What conditions does trial NCT06062342 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT06062342?

The interventions under investigation include: FPI (BEHAVIORAL).

Who is sponsoring clinical trial NCT06062342?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06062342 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.